GMP IPO Watch
Sahajanand Medical Technologies IPO
Sahajanand Medical Technologies IPO details, live grey market premium (GMP), dates, price band, lot size, subscription & review.
Sahajanand Medical Technologies IPO Details
Key facts at a glance| IPO Open Date | 14 October 2026 | IPO Close Date | 18 October 2026 |
|---|---|---|---|
| Basis of Allotment | 20 October 2026 | Listing Date | 22 October 2026 |
| Price Band | ₹327 - ₹344 per share | Face Value | ₹10 per share |
| Market Lot Size | 43 Shares | Min Investment (Retail) | ₹14,792 |
| Total Issue Size | ₹475.48 Cr | Issue Type | Book Built Issue IPO |
| Fresh Issue | — | Offer for Sale (OFS) | ₹475.48 Cr |
| Listing At | BSE, NSE | Issue Category | Mainboard Issue |
| Registrar | MUFG Intime India Pvt. Ltd. | ||
Sahajanand Medical Technologies IPO Timetable (Tentative Dates)
| Event | Tentative Date | Status |
|---|---|---|
| IPO Open Date | 14 October 2026 | Confirmed |
| IPO Close Date | 18 October 2026 | Confirmed |
| Basis of Allotment | 20 October 2026 | Tentative |
| Initiation of Refunds | 22 October 2026 | Tentative |
| Credit of Shares to Demat | 22 October 2026 | Tentative |
| IPO Listing Date | 22 October 2026 | Tentative |
| Cut-off time for UPI Mandate Confirmation | 19 October 2026 (5:00 PM) | Deadline |
* Note: Timelines are tentative and subject to regulatory confirmation. UPI mandate approvals must be completed by 5:00 PM on the IPO closing day.
Sahajanand Medical Technologies IPO Lot Size & Investment Details
Application limits for Retail and HNI investors| Application Category | Lots | Shares | Amount (at Cut-off) |
|---|---|---|---|
| Retail (Min) | 1 Lot | 43 Shares | ₹14,792 |
| Retail (Max) | 13 Lots | 559 Shares | ₹1,92,296 |
| S-HNI (Min) | 14 Lots | 602 Shares | ₹2,07,088 |
| S-HNI (Max) | 67 Lots | 2,881 Shares | ₹9,91,064 |
| B-HNI (Min) | 68 Lots | 2,924 Shares | ₹10,05,856 |
Sahajanand Medical Technologies IPO Live GMP & Movement History
Daily unofficial grey market trends₹27.15 +7.9%
| Date | IPO GMP (₹) | Estimated Listing Price | Estimated Listing Gain (%) |
|---|---|---|---|
| 23 Oct 2026 | ₹17 | ₹361.00 | +4.94% |
| 22 Oct 2026 | ₹15 | ₹359.00 | +4.36% |
| 21 Oct 2026 | ₹24 | ₹368.00 | +6.98% |
| 20 Oct 2026 | ₹25 | ₹369.00 | +7.27% |
| 19 Oct 2026 | ₹25 | ₹369.00 | +7.27% |
| 17 Oct 2026 | ₹15 | ₹359.00 | +4.36% |
| 16 Oct 2026 | ₹40 | ₹384.00 | +11.63% |
| 15 Oct 2026 | ₹45 | ₹389.00 | +13.08% |
| 14 Oct 2026 | ₹42 | ₹386.00 | +12.21% |
| 13 Oct 2026 | ₹42 | ₹386.00 | +12.21% |
| 12 Oct 2026 | ₹46 | ₹390.00 | +13.37% |
| 11 Oct 2026 | ₹40 | ₹384.00 | +11.63% |
Sahajanand Medical Technologies IPO Subscription Status
Demand breakdown by investor categorySahajanand Medical Technologies Company Financials
Restated figures (₹ in Crores)| Period | Total Assets | Total Revenue | Total Expenses | Profit After Tax (PAT) |
|---|---|---|---|---|
| 2024 | 970.58 Cr. | 908.59 Cr. | 875.50 Cr. | 7.35 Cr. |
| 2025 | 1,094.90 Cr. | 1,035.96 Cr. | 980.12 Cr. | 25.15 Cr. |
| 2026 | 1276.43 Cr. | 1218.73 Cr. | 1138.43 Cr. | 69.08 Cr. |
| June 2026 | 1308.100 Cr. | 354.33 Cr. | 330.05 Cr. | 15.09 Cr. |
* Amounts reported in ₹ Crores as sourced from company regulatory filings (RHP/DRHP).
Sahajanand Medical Technologies IPO Valuation & KPIs
Key metrics pre-issueSahajanand Medical Technologies Peer Group Comparison
Listed industry peers| Company Name | P/E | EPS (₹) | RoNW (%) | NAV (₹) | Total Income |
|---|---|---|---|---|---|
| Poly Medicure Limited | 51.40 | 31.79 | 10.37% | 306.40 | 1875.26 Cr. |
| Laxmi Dental Limited | 36.35 | 5.27 | 11.91% | 44.27 | 277.86 Cr. |
About Sahajanand Medical Technologies
Sahajanand Medical Technologies develops, manufactures, and markets cardiovascular devices globally. The core business is divided into two primary segments: vascular intervention products, such as coronary stents and balloon catheters, and structural heart devices, including transcatheter aortic valves and occluders. The company generates the majority of its revenue from the sale of vascular intervention devices, with the Supraflex Cruz, a biodegradable polymer-based drug-eluting stent, acting as a major contributor to its sales. Products are distributed across India, Europe, and the rest of the world through a combination of direct, hybrid, and distributor-led models, supported by an extensive network of domestic and international distributors. Operations are backed by manufacturing facilities located in Surat, Hyderabad, and Thailand. Additionally, the business relies heavily on dedicated research and development capabilities to continually enhance existing products and introduce new cardiovascular treatments.
Sahajanand Medical Technologies IPO Important Dates
| Particular | Dates |
|---|---|
| IPO Open Date | 15 Oct 2026 |
| IPO Close Date | 19 Oct 2026 |
| Basis of Allotment | 21 Oct 2026 |
| Refunds | 22 Oct 2026 |
| Credit to Demat Account | 22 Oct 2026 |
| IPO Listing Date | 23 Oct 2026 |
Note: The timeline for Sahajanand Medical Technologies IPO is tentative and subject to change.
Sahajanand Medical Technologies Objects of the Issue & Utilisation of Proceeds
To Be Updated Soon
Sahajanand Medical Technologies Company Financial Report
| Period | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2024 | 908.59 Cr. | 875.50 Cr. | 7.35 Cr. | 970.58 Cr. |
| 2025 | 1,035.96 Cr. | 980.12 Cr. | 25.15 Cr. | 1,094.90 Cr. |
| 2026 | 1218.73 Cr. | 1138.43 Cr. | 69.08 Cr. | 1276.43 Cr. |
| June 2026 | 354.33 Cr. | 330.05 Cr. | 15.09 Cr. | 1308.100 Cr. |
Note: Financial numbers for Sahajanand Medical Technologies are in ₹ Crores unless stated otherwise.
Sahajanand Medical Technologies Company Valuation & Key Performance Indicators
| KPI | Values |
|---|---|
| ROE | -% |
| ROCE | 11.57% |
| EBITDA Margin | 14.10% |
| PAT Margin | 5.71% |
| Debt to Equity Ratio | – |
| Earning Per Share (EPS) | 6.67 (Basic) |
| Price/Earning P/E Ratio | - |
| Return on Net Worth (RoNW) | 10.60% |
| Net Asset Value (NAV) | 62.76 |
Note: Valuation KPIs for Sahajanand Medical Technologies are computed for FY2026.
Sahajanand Medical Technologies Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Poly Medicure Limited | 31.79 | 51.40 | 10.37% | 306.40 | 1875.26 Cr. |
| Laxmi Dental Limited | 5.27 | 36.35 | 11.91% | 44.27 | 277.86 Cr. |
Note: Peer group comparisons for Sahajanand Medical Technologies are sourced from DRHP filings.
Sahajanand Medical Technologies IPO FAQs
Sahajanand Medical Technologies IPO opens for subscription on 14 October 2026 and closes on 18 October 2026.
The price band for Sahajanand Medical Technologies IPO is set at ₹327.00 to ₹344.00 per share.
The minimum market lot size is 43 shares. A retail investor can apply for a minimum of 1 lot requiring an investment of 43 Shares (₹14,792).
The latest Grey Market Premium (GMP) for Sahajanand Medical Technologies IPO is ₹27.15. GMP represents the unofficial premium at which shares trade prior to listing.
The basis of allotment for Sahajanand Medical Technologies IPO is tentatively scheduled for 20 October 2026, and shares are expected to list on the stock exchanges on 22 October 2026.
MUFG Intime India Pvt. Ltd. is the official registrar for Sahajanand Medical Technologies IPO. Investors can check their IPO allotment status directly on the registrar's portal once finalized.